Particle Size Testing

Poorly soluble APIs now represent the majority of the pharmaceutical development pipeline. Dissolution and oral bioavailability are determined by molecular solubility, surface wetting behavior, solid-state stability, and how the formulation interacts with the GI environment from first contact onward. Amorphous dispersions, lipid systems, nanocrystals, and co-crystals each rely on different surface mechanisms to deliver their intended advantage.

Real-time particle characterization is moving powder processing from delayed laboratory checks toward [...]

Fine powder fluidization can support controlled pneumatic conveying, especially in dense phase [...]

Fines in powder behavior matter because fine particles add surface area, contact [...]

Coated particle damage can change performance before particle size distribution shows a [...]

Metal powder feedstock quality has a direct effect on print stability and [...]

Paint QC can approve a batch that still behaves badly on the substrate. [...]

Powder wettability controls the first contact between powder and liquid. When liquid [...]

Particle size distribution interpretation has the most value when the curve explains [...]

Sieve blinding does more than reduce screening capacity. It changes the [...]

The relevance of powder testing for circular economy powder usage. Circular production [...]

AI-assisted material characterization speeds testing, strengthens models, and improves inline control. Labs [...]